Clinical Trial Update: A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) - [Phase 3]

View source ↗

Summary

This update reports the long-term extension results of lamotrigine (BW430C) in Bipolar I Disorder from the Phase 3 SCA104779 trial (NCT00550407); results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2011-07-27